Cases & Deals

  • Home
  • Practices
  • Merck develops global patent portfolio related to certain bispecific antibodies

Share

Merck develops global patent portfolio related to certain bispecific antibodies

March 2021

Client(s) Merck & Co., Inc.

Jones Day is representing Merck & Co., Inc. in the development and prosecution of a global patent portfolio related to certain bispecific antibodies.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.